CLINICAL_TRIALS
trial_result
· 2022-07-08
Clinical Trial Update: Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer [Phase 2]
Summary
Phase 2 trial update of intraperitoneal aerosol high-pressure chemotherapy for recurrent ovarian cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Ruhr University of Bochum | Conditions: Recurrent Ovarian Cancer | Phase 2 | Status: COMPLETED